[ad_1]
“Sumitomo Chemical would continue to enjoy premium valuations versus domestic peers, given its superior earnings growth outlook, its strong parental advantage, and a robust balance sheet (Rs. 800 crore of cash & cash equivalents as on September 30, 2022),” Abhijeet Bora, deputy vice-president, research, Sharekhan by BNP Paribas, said.
[ad_2]
Source link
